CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4/A Shares withheld for taxes CEO gave up 5,863 shares (to pay taxes)
- 4/A Shares withheld for taxes President & CMO gave up 3,811 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 3,010 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Chairman gave up 10,125 shares (to pay taxes)
- 4 Shares withheld for taxes President & CMO gave up 4,819 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 7,324 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement
- SC 13D/A Stake Beneficial Ownership Report
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 12 of 68 · 1,358 filings